For instance, overexpression of Hsp22 (HspB8) in tau transgenic mice improves cognition and synaptic plasticity by modulating key pathways and upstream regulators of synaptogenesis, including EIF4E and NFKBIA, both of which are emerging biomarkers for AD [90]. The gene discussed is MAPT; the disease is Alzheimer disease.